Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

“…we see great promise in delivering psychedelic-based medicines to treat various diseases and disorders…” Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11- Revive Therapeutics Ltd. (CSE: RVV, US: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased toContinue reading “Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics”

Rapid Dose Therapeutics and McMaster University Initiate QuickStrip™ COVID-19 Vaccine Research With Immediate Impact

— Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has begun COVID-19 vaccine research in conjunction with McMaster University and the team lead by Drs. Alex Adronov, James Mahony, and Mark Larché. The federally-funded project tests the useContinue reading “Rapid Dose Therapeutics and McMaster University Initiate QuickStrip™ COVID-19 Vaccine Research With Immediate Impact”